We performed PALB2 mutation analysis in a series of unrelated French-Canadian women with breast cancer diagnosed at a single hospital in Montreal, Quebec, with the aim of identifying possible founder mutations and determining their contribution to breast cancer. The gene discussed is PALB2; the disease is breast carcinoma.